GlassVC

Hermed Capital

Venture capital firm

Chinese healthcare industry investment fund (Hermed Capital) investing in healthcare companies including biopharmaceutical and bioscience businesses such as Henlius and AADi Bioscience.

Tier 4Basis: No sourced AUM or fund >= $250M in fetched sources (site published in Chinese; description translated from the fetched homepage).

Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

This profile is unclaimed. Built from public sources. If you're a partner or employee at Hermed Capital, you can claim it.

Claim this profileHow claiming works

Key numbers

Assets under management

Not publicly disclosed

LAST CHECKED NOV 2026

Latest fund

HerMed Capital Fund - $100 million (closed 2015, per CB Insights)

Funds

1

Check size

Not publicly disclosed

LAST CHECKED NOV 2026

Stages

No public record

Sectors

BiopharmaceuticalsMedical devicesDiagnosticsHealthcare

FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG

Track record

Outcomes are recorded from public sources and attributed to the firm, not to individual partners. Shutdowns and write-offs are an ordinary part of venture investing; inclusion here is a record, not a judgment.

Hits

  • Henlius

    HerMed team portfolio company Shanghai Henlius listed on the Hong Kong Stock Exchange (2696.HK)

Misses

Track record

No outcomes recorded yet from public sources.

Partners

Partners

No partners listed from public sources.

Reputation

No reputation score — basis not established for this firm.

No reputation sources on file yet.

Suggest a source

Contact

Published sources only

Published contact

Published sources only

GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.

SOURCE: FIRM WEBSITE, AS PUBLISHED 2

What founders say

Founder-submitted · Verified identity and relationship

No founder reviews yet

Be the first founder to share your experience with Hermed Capital. Reviews come from founders whose identity and relationship have been verified.

Write the first review

Methodology

Tier basis — No sourced AUM or fund >= $250M in fetched sources (site published in Chinese; description translated from the fetched homepage). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.

Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.

The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.

Source record 2

  1. [1]

    DATABASE · GlassVC catalog — Catalog record for Hermed Capital — provenance: GlassVC editorial — entered manually

    CATALOG SOURCE FIELD · LAST CHECKED NOV 2026

    ↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Funds · Track record

  2. [2]

    FIRM SITE · Hermed Capital — Firm website, as published by the firm

    LAST CHECKED NOV 2026 ↗

    ↩ cites: Website

PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026